HLK Biotech Holding Group, Inc.
AMHD
$0.0002
$0.000.00%
OTC PK
| 03/31/2000 | 12/31/1999 | 09/30/1999 | |||
|---|---|---|---|---|---|
| Revenue | 357.40K | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 357.40K | -- | -- | ||
| Cost of Revenue | 479.10K | -- | -- | ||
| Gross Profit | -121.70K | -- | -- | ||
| SG&A Expenses | 438.10K | -- | -- | ||
| Depreciation & Amortization | 9.60K | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 926.80K | -- | -- | ||
| Operating Income | -569.50K | -- | -- | ||
| Income Before Tax | -573.70K | -- | -- | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -573.70K | -- | -- | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -573.70K | -- | -- | ||
| EBIT | -569.50K | -- | -- | ||
| EBITDA | -566.80K | -- | -- | ||
| EPS Basic | -4.25M | -- | -- | ||
| Normalized Basic EPS | -- | -- | -- | ||
| EPS Diluted | -- | -- | -- | ||
| Normalized Diluted EPS | -- | -- | -- | ||
| Average Basic Shares Outstanding | -- | -- | -- | ||
| Average Diluted Shares Outstanding | -- | -- | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||